Pathology and histoprognosis of differentiated follicular thyroid carcinoma;Anatomo-pathologie et histopronostic des carcinomes thyroidiens differencies d'origine folliculaire

Annales d'Endocrinologie

Volumn 58, Issue 3, 1997, Pages 172-182

  De Micco, C ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CELL PROLIFERATION; DISEASE CLASSIFICATION; DNA CONTENT; HISTOPATHOLOGY; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MOLECULAR EVOLUTION; NONHUMAN; REVIEW; THYROID FOLLICULAR CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; HUMANS; NEOPLASM METASTASIS; PROGNOSIS; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030996581     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. AIN KB. Papillary thyroid carcinoma : Etiology, assessment, and therapy. Endocrinol Metab Clin N Amer 1995 ; 24: 711-60.
2. AKSLEN LA. Prognostic Importance of Histologic Grading in Papillary Thyroid Carcinoma. Cancer 1993 ; 72 : 2680-5.
3. AKSLEN LA, VARHAUG JE. Oncoproteins and tumor progression in papillary thyroid carcinoma : Presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21- ras protein, and proliferation indicators in relation to tumor recurrences and patient survival. Cancer 1995 ; 76 : 1643-54.
4. ALBORES-SAAVEDRA J, GOULD E, VARDAMAN C, VUITCH F. The macrofollicular variant of papillary thyroid carcinoma : a study of 17 cases. Hum Pathol 1991 ; 22 : 1195-205.
5. ALLO MD, CHRISTIANSON W, KOIVUNEN D. Not all « occult » papillary carcinomas are « minimal ». Surgery 1988 ; 104 : 971-6.
6. BASOLO F, FUGAZZOLA L, FONTANINI G, ELISEI R, PEPE S, BEVILACOUA G, et al. Markers of cell proliferation as prognostic factors in differentiated thyroid cancer. Int J Oncol 1993 ; 3 : 1077-81.
7. BASOLO F, PINCHERA A, FUGAZZOLA L, FONTANINI G, LISEI R, ROMEI C, et al. Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer. Eur J Cancer 1994 ; 30A : 171-4.
8. BECKNER ME, HEFFESS CS, OERTEL JE. Oxyphilic papillary thyroid carcinomas. Am J Clin Pathol 1995 ; 103 : 280-7.
9. BRENNAN MD, BERGSTRALH EJ, VAN HEERDEN JA, MCCONAHEY WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970 : Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991 ; 66 : 11-22.
10. BUGIS SP, YOUNG EM, ARCHIBALD LD, CHEN VS. Diagnostic accuracy of fineneedle aspiration versus frozen section in solitary thyroid nodules. Am J Surg 1986 ; 152 : 411-6.
11. BURMAN KD, RINGEL MD, WARTOFSKY L. Unusual types of thyroid neoplasms. Endocrinol Metab Clin N Amer 1996 ; 25 : 49-68.
12. CARCANGIU ML, ZAMPI G, PUPI A, CASTAGNOLI A, ROSAI J. Papillary carcinoma of the thyroid : a clinicopathologic study of 241 cases treated at the university of Florence, Italy. Cancer 1985 ; 55 : 805-28.
13. CARCANGIU ML, ZAMPI G, ROSAI J. Papillary thyroid carcinoma : a study of its many morphologic expressions and clinical correlates. Pathol Annu 1985 ; 20 : 1-44.
14. CHAN JK. Papillary carcinoma of thyroid : classical and variants. Histol Histopath 1990 ; 5 : 241-57.
15. DAMIANI S, DINA R, EUSEBI V. Cytologic grading of aggressive and nonaggressive variants of papillary thyroid carcinoma. Am J Clin Pathol 1994 ; 101 : 651-5.
16. DE MICCO C. Carcinomes thyroïdiens différenciés d'origine folliculaire : faits nouveaux en 1988. Arch Anal Cytol Path 1989 ; 37 : 21-8.
17. DE MICCO C. La cytologie thyroidienne, bilan et perspectives. Ann Endocrinol 1993 ; 54 ; 258-63.
18. DE MICCO C, VASKO V, GARCIA S, ZORO P, DENIZOT A, HENRY J. Fine-needle aspiration of thyroid follicular neoplasms : Diagnostic use of thyroid peroxidase immunocytochemisry with monoclonal antibody 47. Surgery 1994 ; 116 : 1031-5.
19. DE MICCO C, ZORO P, GARCIA S, SKOOG L, TANI E, CARAYON P, et al. Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine needle biopsy Eur J Endocrinology 1994 ; 131 : 474-9.
20. DEGROOT LJ, KAPLAN EL, SHUKLA NS, SALTI G, STRAUS FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 1995 ; 80 : 2946-53.
21. DELISLE MJ, SCHVARTZ C, THEOBALD S, MAES B, VAUDREY C. POCHART JM The thyroid carcinomas. Interest of a regional registry of 627 patients diagnosed, treated and followed by a multidisciplinary group. Ann Endocrinol 1996 : 57 : 41-9.
22. DOBASHI Y, SAKAMOTO A, SUGIMURA H, MERNYEI M, MORI M, OYAMA T, et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 1993 ; 17 : 375-81.
23. DONOHUE JH, GOLDFIEN SD, MILLER TR, ABELE JS, CLARK OH Do the prognoses of papillary and follicular thyroid carcinomas differ ? Am J Surg Pathol 1984 ; 148 : 168-73.
24. EVANS HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol 1986 ; 85 : 77-80.
25. EVANS HL. Encapsulated papillary neoplasms of the thyroid. Am J Surg Pathol 1987 ; 11 : 592-7.
26. FAGIN JA Tumor suppressor genes in human thyroid neoplasms p53 mutations are associated undifferentiated thyroid cancers. J Endocrinol Invest 1995 ; 18 : 140-2.
27. FURMANCHUK AW, AVERKIN JI, EGLOFF B, RUCHTI C, ABELIN T, SCHAPPI W, et al. Pathomorphological findings in thyroid cancers of children from the republic of belarus - A study of 86 cases occurring between 1986 (Post-Chernobyl) and 1991. Histopathology 1992 ; 21 : 401-8.
28. GAERTNER EM. DAVIDSON M, WENIG BM. The columnar cell variant of thyroid papillary carcinoma - Case report and discussion of an unusually aggressive thyroid papillary carcinoma. Am J Surg Pathol 1995 ; 19 : 940-7.
29. GREBE SKG, HAY ID. Follicular thyroid cancer. Endocrinol Metab Clin N Amer 1995 ; 24 : 761-801.
30. HAMMING J, van de VELDE C, van STEENIS G, van RAVENSWAAY CLAASEN H, GOSLINGS B, HERMANS J Fineneedle aspiration biopsy and frozen section in nodular thyroid disease. In . Differentiated thyroid cancer : current considerations on diagnosis and surgical treatment. HAMMING JF. Éd. Drukkerij Grœn Bv., Leiden, 1988, pp 25-35.
31. MANNEQUIN PL, LIEHN JC, DEUISLE MJ. Multifactorial analysis of survival in thyroid cancer. Cancer 1986 ; 58 : 1749-55.
32. HAWK WA, HAZARD JB. The many appearances of papillary carcinoma of the thyroid. Clev Clin Q 1996 ; 43 : 207-16.
33. HAY D, GRANT CS, VANHEERDEN JA, GœLLNER JR, EBERSOLD JR, BERGSTRALH EJ, et al. Papillary thyroid microcarcinoma - A study of 535 cases observed in a 50-year period. Surgery 1992 ; 112 : 1139-47.
34. HAY I, GRANT C, TAYLOR W, MCCONAHEY W. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma : a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987 : 102 : 1088-95.
35. HAY ID, BERGSTRALH EJ, GœLLNER JR, KATZMANN JA, RYAN JJ, WU PS, VAN HEERDEN JA, GRANT CS. Nondiploid nuclear DNA content : a relevant prognostic indicator in 769 surgically traeted cases of differentiated thyroid cancer. In : Progress in Thyroid Research. Ed. Gordon, Gross & Hennemann, Balkema, Rotterdam, 1991, 329 pp.
36. HAY ID, BEROSTRALH EJ, GœLLNER JR, EBERSOLD JR, GRANT CS, CARTY SE, et al. Predicting outcome in papillary thyroid carcinoma - Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993 ; 114 : 1050-8
37. HEDINGER CE, WILLIAMS ED, SOBIN LH. Histological typing of thyroid tumours Ed. Springer-Verlag, Berlin, Heidelberg, New York, London. Paris, Tokyo, Hong Kong, 1988
38. HENRY JF, AUDIFFRET J, DENIZOT A, BORDIGONI L, DE MICCO C. Envahissement intra-thyroidien et ganglionnaire des cancers thyroidiens différenciés. Rev Franç Endocrinol Clin 1989 ; 30 : 13-20.
39. HERRERA MF, HAY ID, WU PSC. Hürthle cell (oxyphilic) papillary thyroid carcinoma : a variant with more aggressive biological behavior. World J Surg 1995 ; 3 : 280-1.
40. HORI Y, KASHIMA K, DAA T, YOKOYAMA S, NAKAYAMA I, NOGUCHI S. Relationship between cell proliferation activity and morphological characteristics of papillary microcarcinoma in the thyroid of Graves' disease Pathol Int 1995 ; 45 : 846-53.
41. IIDA F, SUGENOYA A, MURAMATSU A. Clinical and pathologic properties of small differentiated carcinomas of the thyroid gland. World J Surg 1991 ; 75 : 511-5.
42. JOHNSON TL, LLOYD RV, THOMPSON NW, BEIERWALTES WH, SISSON JC. Pronostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 1988 ; 12 : 22-7.
43. JONASSON JG, HRAFNKELSSON J. Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland - A nationwide study in Iceland on carcinomas diagnosed 1955-1990. Virchows Archiv A Patho Anal 1994 ; 425 : 349-55.
44. JORDA M, GONZALEZ-CAMPORA R, MORA J, HERRERO-ZAPATERO A, OTAL C, GALERA H. Prognostic factors in follicular carcinoma of the thyroid. Arch Pathol Lab Med 1993 ; 117 : 631-5.
45. KASAI N, SAKAMOTO A. New subgrouping of small shyroid carcinomas. Cancer 1987 ; 60 : 1767-70.
46. LANG W, BORRUSCH H, BAUER L Occult carcinomas of the thyroid. Evaluation of 1.020 sequential autopsies. Am J Clin Path 1988 ; 90 : 72-6
47. LANG WC, CHORITZ H, HUNDESHAGEN H. Risk factors in follicular thyroid carcinomas a retrospective follow-up study covering a 14 year period with emphasis on morphological findings. Am J Surg Pathol 1986 ; 10 : 246-55.
48. LAYFIELD LJ, MOHRMAN RL, KOPALD KH, GIULIANO AE. Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules Cancer 1991 ; 68 : 130-4.
49. LINDSAY S. Papillary thyroid carcinoma revisited. In : Thyroid Cancer. UICC Monograph Series Vol 12. éd. Hedinger C, Springer, Berlin. Heidelberg, New York. 1969.
50. LIVOLSI V,. Surgical Pathology of the Thyroid, éd. W.B. Saunders Company, Philadelphia, 1990.
51. LIVOLSI VA. Papillary neoplasms of the thyroid. Am J Clin Path 1992 ; 97 : 426-34.
52. MATSUBAYASHI S, KAWAI K, MATSUMOTO Y, MUKUTA T, MORITA T, HIRAI K, et al. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 1995 ; 80 : 3421-4.
53. MAZZAFERRI EL, JHIANG SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994 ; 97 : 418-28.
54. MCHENRY C, ROSEN I, WALFISH P, BEDARD Y. Influence of fine-needle aspiration biopsy and frozen section examination on the management of thyroid cancer. Am J Surg 1993 ; 166 : 353-6.
55. MIZUKAMI Y, MISHIGISHI T, NONOMURA A, NOGUCHI M, NAKAMURA H. Thyroid carcinoma : clinical, pathologic correlations. Crit Rev Oncol Hematol 1995 ; 18 : 67-102.
56. MIZUKAMI Y, NONOMURA A, MICHIGISHI T, NOGUCHI M, NAKAMURA S, HASHIMOTO T. Tumor proliferation-related markers in papellary thyroid carcinomas - correlation with histologic subtypes - Clinical study. Anticancer Res 1993 ; 13 : 267-72.
57. MIZUKAMI Y, NONOMURA A, MICHIGISHI T, NOGUCHI M, NAKAMURA S, HASHIMOTO T. Columnar cell carcinoma of the thyroid gland : a case report and review of the literature. Hum Pathol 1994 ; 25 : 1098-101.
58. MIZUKAMI Y, NONOMURA A, MICHIGISHI T, NOGUCHI M, NAKAMURA S, HASHIMOTO T. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors : An immunohistochemical study. Anticancer Res 1995 ; 15 : 755-9.
59. MIZUKAMI Y, NONOMURA A, MICHIGISHI T, OHMURA K, NOGUCHI M, ISHIZAKI T. Diffuse follicular variant of papillary carcinoma of the thyroid. Histopathology 1995 ; 27 : 575-7.
60. MORENO-EGEA A, RODRIGUEZ-GONZALEZ JM, SOLA-PEREZ J. SORIA-COGOLLOS T, PARRILLA-PARICIO P. Multivariate analysis, of histopathological features as prognostic factors in patients with papillary thyroid carcinoma. Br J Surg 1995 ; 82 : 1092-4.
61. NISHIDA T, NAKAO F, HAMAJI M, NAKAHARA M, TSUJIMOTO M. Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer. Surgery 1996 ; 119 : 568-75.
62. NOGUCHI S, MURAKAMI N, KAWAMOTO H. Classification of papillary cancer of the thyroidbased on prognosis. World J Surg 1994 ; 18 : 552-8.
63. NOGUCHI S, YAMASHITA H. MURAKAMI N, NAKAYAMA I, TODA M, KAWAMOTO H. Small carcinomas of the thyroid : A long-term follow-up of 867 patients. Arch Surg 1996 ; 131 : 187-91.
64. OERTEL YC. Diagnosis of thyroid nodules by fine needle aspiration - Comment. J Clin Endocrinol Metab 1995 : 80 : 1467-8.
65. OYAMA T, ISHIDA T, ISHII K, SAKURAI S, JOSHITA T, SAKAMOTO A, et al. Encapsulated papillary carcinoma of the thyroid gland - clinicopathological and cytofluorometric study in comparison with non-encapsulated papillary carcinoma. Acta Pathol Jpn 1993 ; 43 : 516-21.
66. OZAKI O, ITO K, MIMURA T, SUGINO K, HOSODA Y. Papillary carcinoma of the thyroid : tall-cell variant with extensive lymphocyte infiltration. Am J Surg Pathol 1996 ; 20 : 695-8.
67. PAPOTTI M, MICCA FB, FAVERO A. PALESTINI N, BUSSOLATI G. POORLY differentiated thyroid carcinomas with primordial cell component - A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 1993 ; 17 : 291-301.
68. PASIEKA JL, ZEDENIUS J, AUER G, GRIMELIUS L, HOOG A, LUNDELL G, et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992 ; 112 : 1154-60.
69. PEIX JL, MASSARD JL, BERGER N, BERNARD MH. Étude comparative des données de la cytoponction pré-opératoire et de l'examen anatomo-pathologique extemporanné dans le traitement chirurgical des nodules thyroidiens. Lyon Chir 1990 ; 86 : 98-100
70. POLLINA L, PACINI F, FONTANINI G. VIGNATI S, BEVILACOUA G, BASOLO F. bcl-2. p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. Br J Cancer 1996 ; 73 : 139-43.
71. PROYE C, LECOMTE-HOUCKE M, DA COUTO FERREIRA-BRANCO F, DECOULX M, LEFEBVRE J, FOSSATI P. Examen cytologique et examen extemporanné du nodule thyroidien. Point de vue du consommateur. Les abandonner ou les associer ?. Rev Franc Endocrinol Clin 1989 ; 30 : 275-9.
72. ROSAI J, CARCANGIU ML, DELELLIS RA. Atlas of Tumor Pathology. Tumors of the Thyroid Gland, éd. Armed Forces Institute of Pathology, Washington DC, 1992.
73. SAKAMOTO A, KASAI N, SUGANO H. Poorly differentiated carcinoma of the thyroid. Cancer 1983 ; 52 : 1849-55.
74. SAMPSON RJ, OKA H, KEY CR, BUNCHER CR, IUIMA S. Metastases from occult thyroid carcinoma. Cancer 1970 ; 25 : 803-11.
75. SAPI Z, LUKACS G, SZTAN M, PAPP J, OLAH E. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma. Diagn Mol Pathol 1995 ; 4 : 256-60.
76. SCHELFHOUT LC, CREUTZBERG CL, HAMMING JF, FLEUREN GJ, SMEENK D, HERMANS JO, et al. Multivariate analysis of survival in differentiated thyroid cancer : the prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988 ; 24 : 331-7.
77. CHEUMMAN GFW, HOANGVU C, CETIN Y, GIMM O, BEHRENDS J, VONWASIELEWSKI R, et al. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metab 1995 ; 80 : 2168-72.
78. SCHROUDER S, BAY V, DUMKE K. KREMENS B, MUÜLLER-GARTNER HW, BOÖCKER W, et al. Diffuse sclerosing variant of papillary thyroid carcinoma. Virchows Archiv A Pathol Anat 1990 ; 416 : 367-71.
79. SCHROÖDER S, BOÖCKER W, DRALLE H, KORTMAN KB, STERN C. The encapsulated papillary carcinoma of the thyroid. Cancer 1984 ; 54 : 90-3.
80. SERINI G, TRUSOLINO L, SAGGIORATO E, CREMONA O. DEROSSI M, ANGELIA, et al. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J Nat Cancer Inst 1996 ; 88 : 442-9.
81. SHAHA AR, LOREE TR, SHAH JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995 ; 118 : 1131-8.
82. IMPSON W, MCKINNEY S, CARRUTHERS J, GOSPODAROWICZ M, SUTCLIFFE S, PANZARELLA T. Papillary and follicular thyroid cancer. Prognostic factors in 1578 patients. Am J Med 1987 ; 83 : 479-88.
83. SOARES J, LIMBERT E, SOBRINHO-SIMŒS M. Diffuse sclerosing variant of papillary thyroid carcinoma. Path Res Pract 1989 ; 185 : 200-6.
84. SOARES P, CAMESELLE-TEIJEIRO J, SOBRINHO-SIMŒS M. Immuno-histochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 1994 ; 24 : 205-10.
85. SOARES P, SOBRINHO-SIMŒS M. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer 1994 ; 73 : 2879-80.
86. SOBRINHO-SIMŒS M. Poorly Differentiated Carcinoma of the Thyroid. Am J Clin Pathol 1988 ; 89 : 264-7.
87. OBRINHO-SIMŒS M. Thyroid Oncology : The End of The Dogmas. Int J Endocrinol 1991 ; 2 : 117-9.
88. SOBRINHO-SIMŒS M. Poorly differentiated carcinomas of the thyroid. Endocr Pathol 1996 ; 7 : 99-102.
89. SOBRINHO-SIMŒS M, SOARES J, CARNEIRO F, LIMBERT E. Diffuse follicular variant of papillary carcinoma of the thyroid : report of eight cases of a distinct agressive type of thyroid tumor. Surg Pathol 1990 ; 3 : 189-203.
90. TENNVALL J, BIOÖRKLUND A, MOOLLER T, RANSTAM J, AKERMAN M. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma ? Cancer 1986 ; 57 : 1405-14.
91. TERRY JH, STJOHN SA, KARKOWSKI FJ, SUAREZ JR, YASSA NH, PLATICA CD, et al. Tall cell papillary thyroid cancer : incidence and prognosis. Am J Surg 1994 ; 168 : 459-61.
92. TSCHOLL-DUCOMMUN J, HEDINGER CE. Papillary thyroid carcinomas. Morphology and prognosis. Virchows Archiv A Pathol Anal 1982 ; 396 : 19-39.
93. TUBIANA M, SCHLUMBERGER M, ROUGIER P, LAPLANCHE A, BENHAMOU H, GARDET P, et al. Long term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985 ; 55 : 794-804.
94. VANHEERDEN JA, HAY ID, GŒLLNER JR, SALOMAO D, EBERSOLD JR, BERGSTRALH EJ, et al. Follicular thyroid carcinoma with capsular invasion alone - A non threatening malignancy. Surgery 1992 ; 112 : 1130-38.
95. ZEDENIUS J, LARSSON C, WALLIN G, BACKDAHL M, AsPENBLAD U, HOOG A, et al. Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. Thyroid 1996 ; 6 : 1-9.
96. ZORO P, VASSKO V, GARCIA S, PAZART L, AHO S, DE MICCO C. Marqueurs de malignité dans le cytodiagnostic des nodules thyroidiens. Révélation de l'activité dipeptidyl aminopeptidase IV (DAP IV). Ann Pathol 1996 ; 16 : 261-5.